reglab/statecodes huggingface dataset:
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-23 - PHYSICIAN REENTRY INTO PRACTICE › Section 540-X-23-.03 - Reentry To Practice Rule

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A
			 physician's absence from clinical practice for more than two years creates a
			 rebuttable presumption of clinical incompetence. A physician, whether he or she
			 is an applicant or licensee, who has not actively practiced or who has not
			 maintained continued competency, as determined by the Board, during the
			 two-year period immediately preceding the filing of an application for
			 licensure or reinstatement or during any consecutive two-year period may be
			 required to complete a reentry plan as a condition of
			 licensure/reinstatement.
(2) The
			 reentry plan may contain any or all of the following:
(a) An assessment of the physician's current
			 strengths and weaknesses in his or her intended area(s) of practice. The
			 process may include testing and evaluation by colleagues, educators, or any
			 other person or entity approved by the Board or Commission.
(b) The physician must also obtain education.
			 Education shall address the applicant's area(s) of needed improvement and
			 consist of a reentry period of retraining and education upon terms based on the
			 factors set forth in Paragraph (3) of this rule.
(c) Depending upon the amount of time
			 out-of-practice, the physician may be required to complete one or more of the
			 following:
1. Receive a passing score on the
			 Special Purpose Examination ("SPEX") or the Comprehensive Osteopathic Medical
			 Variable-Purpose Examination ("COMVEX") examination;
2. Participate in a national assessment
			 readiness program;
3. Undergo a
			 competency assessment by the Board and/or the Commission;
4. Practice for a specified period of time
			 under a mentor/supervising physician who will provide periodic reports to the
			 Board;
5. Obtain certification or
			 recertification by a specialty board recognized by the American Board of
			 Medical Specialties ("ABMS") or the American Osteopathic Association's ("AOA")
			 Bureau of Osteopathic Specialists;
6. Complete one year of accredited
			 postgraduate or clinical fellowship training, which must be preapproved by the
			 Board;
7. Complete up to 50 hours
			 of Board-approved continuing medical education each year that the agreement is
			 in place.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-24 - PHYSICIAN ASSISTANT REENTRY INTO PRACTICE › Section 540-X-24-.01 - Definitions

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Active
			 Practice: A physician assistant may be said to be in active clinical practice
			 when any amount of direct patient care has been provided during the preceding
			 two years.
(2) Direct Patient Care:
			 Direct patient care has been provided when a physician assistant treats, or
			 professes to diagnose, treat, or prescribe medication to a patient for any
			 physical ailment or injury in a clinical or professional setting.
(3) Burden of Proof: The reentry candidate
			 shall have the burden of providing appropriate proof of direct patient care.
			 Ideally, such proof will include a patient chart but may include other
			 documentation as deemed appropriate by the Board.
(4) Two-Year Period: The beginning of the
			 two-year period will begin from the date the physician assistant last provided
			 direct patient care and will be tolled by the filing of an initial or
			 reinstatement application for a license to practice as a physician
			 assistant.
(5) Board: Alabama Board
			 of Medical Examiners.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53,
				  34-24-53.1,
				  34-24-293,
				  34-24-298,
				  34-24-302,
				  34-24-303,
				  34-24-306.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-24 - PHYSICIAN ASSISTANT REENTRY INTO PRACTICE › Section 540-X-24-.02 - Application

Current through Register Vol. 42, No. 9, June 28, 2024
(1) This rule shall
			 apply in the following instances:
(a)
			 Physician assistant applicants seeking a license to practice, who otherwise
			 qualify for a license, but who have been absent from clinical practice for two
			 years or more may obtain a license by entering into a reentry agreement with
			 the Board.
(b) Licensees seeking
			 reinstatement of a license may be ordered to complete a reentry plan as a
			 condition of reinstatement. Licensees whose reinstatement is contested and
			 whose license is reinstated shall be required to complete a reentry plan as
			 part of the reinstatement order.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-24 - PHYSICIAN ASSISTANT REENTRY INTO PRACTICE › Section 540-X-24-.03 - Reentry To Practice Rule

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A
			 physician assistant's absence from clinical practice for more than two years
			 creates a rebuttable presumption of clinical incompetence. A physician
			 assistant, whether he or she is an applicant or licensee, who has not actively
			 practiced or who has not maintained continued competency, as determined by the
			 Board, during the two-year period immediately preceding the filing of an
			 application for licensure or reinstatement or during any consecutive two-year
			 period may be required to complete a reentry plan as a condition of licensure
			 or reinstatement.
(2) The reentry
			 plan may contain any or all of the following:
(a) An assessment of the physician
			 assistant's current strengths and weaknesses in his or her intended area(s) of
			 practice. The process may include testing and evaluation by colleagues,
			 educators, or any other person or entity approved by the Board.
(b) The physician assistant must also obtain
			 education. Education shall address the applicant's area(s) of needed
			 improvement and consist of a reentry period of retraining and education upon
			 terms based on the factors set forth in Paragraph (3) of this rule.
(c) Depending upon the amount of time
			 out-of-practice, the physician assistant may be required to complete one or
			 more of the following:
1. Receive a passing
			 score on the Physician Assistant National Certifying Exam ("PANCE") or the
			 Physician Assistant National Recertifying Exam ("PANRE") examination or any
			 other competency exam endorsed by the National Commission on Certification of
			 Physician Assistants;
2.
			 Participate in a national assessment readiness program;
3. Undergo a competency assessment by the
			 Board;
4. Practice for a specified
			 period of time under a restricted registration agreement, skills protocol, and
			 job description approved by the Board;
5. Complete up to 50 hours of Board-approved
			 continuing medical education each year that the agreement is in
			 place.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.01 - Preamble

Current through Register Vol. 42, No. 9, June 28, 2024
This Chapter implements the provisions of the Darren Wesley "A
				to" Hall Compassion Act (Act 2021-450;
Code of Ala.
				1975
, §§
								20-2A-1, et. seq.) relating to the
				physician recommendation of medical cannabis. This Chapter shall establish the
				eligibility requirements and process for a licensed physician to qualify as a
				registered certifying physician. This Chapter will also establish the
				requirements for a registered certifying physician to issue a physician
				certification for a patient to use medical cannabis. Nothing in this Chapter
				shall overrule, modify, or replace the Board's regulations on prescribing
				controlled substances and standards for pain management services, as these
				regulations also apply to a physician's recommendation of medical cannabis. In
				particular, physicians should exercise diligence in utilizing the Board's Risk
				and Abuse Mitigation Strategies contained in Ala. Admin. Code r.
				540-X-4-.09. Even though a
				physician's recommendation or certification of a patient's use of medical
				cannabis is not a prescription, given the same risks for abuse and diversion,
				the Board expects the same standard of care and discretion to be observed by
				physicians as would be for any other treatment utilizing controlled
				substances.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53,
				  34-24-53.1; Act 2021-450,
				  (
Code of Ala. 1975
, §§
										20-2A-1, et. seq.).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.03 - Registration Of Physicians For Certifying The Use Of Medical Cannabis

Current through Register Vol. 42, No. 9, June 28, 2024
Every physician licensed to practice in Alabama who certifies
				or recommends a patient for the use of medical cannabis within Alabama pursuant
				to
Code of Ala. 1975
, §§
								20-2A-1, et. seq. or who proposes
				to certify or recommend a patient for the use of medical cannabis within
				Alabama must obtain annually an Alabama Medical Cannabis Certification Permit
				from the Board.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53,
				  34-24-53.1; Act 2021-450
				  (
Code of Ala. 1975
, §§
										20-2A-1, et.
				  seq.)
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.04 - Requirements For Initial Application For Alabama Medical Cannabis Certification Permit

Current through Register Vol. 42, No. 9, June 28, 2024
(1) To obtain
			 an Alabama Medical Cannabis Certification Permit, a physician applicant shall
			 submit the following to the Board:
(a) A
			 completed application on a form prescribed by the Board.
(b) Proof of an active, unrestricted license
			 to practice medicine or osteopathy in Alabama.
(c) Proof of an active, unrestricted Alabama
			 Controlled Substances Certificate (ACSC).
(d) Proof of an active, unrestricted,
			 Alabama-specific DEA registration.
(e) Proof of a current registration to query
			 the Alabama Prescription Drug Monitoring Program (PDMP) that is established and
			 maintained by the Alabama Department of Public Health.
(f) Proof of a current registration, or
			 immediate intent to register, with the Alabama Medical Cannabis Patient
			 Registry System that is established and maintained by the AMCC.
(g) Proof of completion of a four (4) hour
			 course related to medical cannabis, and a passing grade on a subsequent
			 examination, which has been approved by the Board and offered by a
			 multi-specialty statewide professional organization of physicians in this state
			 that is recognized to accredit intrastate organizations to provide AMA PRA
			 Category 1 CreditT.
(h) The
			 disclosure of any controlled substances certificate or registration denial,
			 restriction, or discipline imposed on the physician applicant, or any
			 disciplinary act against any medical or other professional license of the
			 physician applicant.
(i) A list of
			 all practice locations and/or addresses from which the physician applicant may
			 certify or recommend a patient for the use of medical cannabis.
(j) An initial/reinstatement application fee
			 of three hundred dollars ($300), which shall be payable to the Board and
			 non-refundable upon submission. An initial/reinstatement application fee is
			 non-transferable.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.05 - Physician Eligibility For An Alabama Medical Cannabis Certification Permit

Current through Register Vol. 42, No. 9, June 28, 2024
No physician shall obtain an Alabama Medical Cannabis
				Certification Permit unless he or she:
(1) Possesses an active, unrestricted license
			 to practice medicine or osteopathy in Alabama;
(2) Possesses an active, unrestricted ACSC
			 registration;
(3) Possesses an
			 active, unrestricted, Alabama-specific DEA registration;
(4) Has satisfied one of the following
			 experience requirements:
(a) Has been engaged
			 in the active practice of medicine or osteopathy for at least three (3) years,
			 excluding any practice in an internship, residency, fellowship, or other
			 supervised training program; or
(b)
			 Has actively practiced medicine or osteopathy for at least one (1) year,
			 excluding any practice in an internship, residency, fellowship, or other
			 supervised training program, and is certified by a specialty board approved by
			 the American Board of Medical Specialties (ABMS) or the American Osteopathic
			 Association Bureau of Osteopathic Specialists (AOABOS);
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.06 - Grounds For Denial Or Revocation Of An Alabama Medical Cannabis Certification Permit

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The Board
			 may deny issuance or renewal of or revoke the Alabama Medical Cannabis
			 Certification Permit of a physician who:
(a)
			 Fails to meet or maintain any of the requirements set forth in
Code
			 of Ala. 1975
, §§
									20-2A-1, et seq., or Ala. Admin.
			 Code R. 540-X-25-.01, et seq.;
(b) Furnishes false, misleading, untruthful,
			 or fraudulent information in connection with an application;
(c) Discloses, or fails to disclose, any
			 controlled substances certificate or registration denial, restriction, or
			 discipline imposed on the applicant, or any disciplinary act against any
			 medical license, any controlled substances certificate of registration, or any
			 DEA registration of the physician;
(d) Has been convicted of, pled guilty to, or
			 entered a plea of nolo contendere to a felony or a criminal offense related to
			 the provision of medical services, fraud, or a drug offense, or is under any
			 state or federal restriction, probation, discipline, investigation, or
			 indictment related to a felony, the provision of medical services, fraud, or a
			 drug offense;
(e) Holds a direct or
			 indirect economic interest in a licensee of the AMCC;
(f) Is guilty of any of the acts or offenses
			 listed in
Code of Ala. 1975
, §
									34-24-360; or
(g) Has violated any rules or regulations of
			 the Board or the Medical Licensure Commission of Alabama.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.07 - Renewal Of An Alabama Medical Cannabis Certification Permit

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Renewal of an
			 Alabama Medical Cannabis Certification Permit shall be annually on or before
			 December 31 of each year.
(2)
			 Annual permit renewal shall occur upon completion of a renewal application in a
			 form prescribed by the Board and payment of a renewal fee.
(3) The fee for annual permit renewal shall
			 be two hundred dollars ($200).
(4)
			 Any registered certifying physician who fails to renew an Alabama Medical
			 Cannabis Certification Permit by December 31 of the year of its expiration
			 shall be required to reinstate the certificate by reapplying for an initial
			 Alabama Medical Cannabis Certification Permit under the provisions set forth in
			 this Chapter.
(5) Before renewing
			 an Alabama Medical Cannabis Certification Permit, a physician shall have a
			 current and appropriate registration issued by the DEA and a valid ACSC
			 registration issued by the Board.
(6) Before renewing an Alabama Medical
			 Cannabis Certification Permit, a physician shall have a current registration to
			 access and query in all locations where he or she certifies or recommends a
			 patient for the use of medical cannabis:
(a)
			 The Alabama Medical Cannabis Patient Registry system established and maintained
			 by the AMCC; and
(b) The
			 PDMP.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.08 - Continuing Medical Education Requirements

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Prior to the initial issuance of, or
			 reinstatement thereof, an Alabama Medical Cannabis Certification Permit, a
			 physician shall have, within the two (2) years preceding their application,
			 completed a four (4) hour course related to medical cannabis, and have received
			 a passing grade on a subsequent examination, which has been approved by the
			 Board and offered by a multi-specialty statewide professional organization of
			 physicians in this state that is recognized to accredit intrastate
			 organizations to provide AMA PRA Category 1 CreditT.
(2) In order to maintain or renew an Alabama
			 Medical Cannabis Certification Permit, a registered certifying physician shall,
			 every two (2) years, complete a two (2) hour refresher course related to
			 medical cannabis which has been approved by the Board and offered by a
			 multi-specialty statewide professional organization of physicians in this state
			 that is recognized to accredit intrastate organizations to provide AMA PRA
			 Category 1 CreditT.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53,
				  34-24-53.1; Act 2021-450 (
Code of Ala. 1975
, §§
										20-2A-1, et.
				  seq.)
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.10 - Requirements For Physician Recommendation Or Certification For The Use Of Medical Cannabis

Current through Register Vol. 42, No. 9, June 28, 2024
(1) In
			 order to recommend a patient for the use of medical cannabis, a registered
			 certifying physician shall, within the scope of his or her usual medical
			 practice or specialty, diagnose a patient with at least one qualifying medical
			 condition or shall confirm, through personal, direct observation and assessment
			 and primary source verification, that the patient has been medically diagnosed,
			 by a physician, with at least one qualifying medical condition.
(2) A registered certifying physician shall
			 establish a bona fide physician-patient relationship with the patient for the
			 provision of medical services in an in-person visit that complies with this
			 Chapter and for which there is an expectation that the physician will provide
			 care to the patient on an ongoing basis.
(a)
			 Prior to certifying or recommending, or recertifying or re-recommending, a
			 patient for the use of medical cannabis, the registered certifying physician
			 shall have conducted a physical examination while physically present in the
			 same room as the patient and obtained a full assessment of the patient's
			 medical history. Any certification or recommendation, or recertification or
			 re-recommendation, of a patient for the use of medical cannabis must also occur
			 with the registered certifying physician and the qualified patient physically
			 present in the same room.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-25 - PHYSICIAN RECOMMENDATION OF THE USE OF MEDICAL CANNABIS › Section 540-X-25-.11 - Dosage Limitations Of Medical Cannabis Recommendations

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A registered
			 certifying physician may not lawfully recommend the use of medical cannabis
			 with a potency greater than three percent (3%) tetrahydrocannabinol to any
			 minor for any qualifying medical condition.
(2) A registered certifying physician shall
			 not recommend a dosage of tetrahydrocannabinol content which exceeds the
			 maximum daily dosage of medical cannabis for the applicable qualifying medical
			 condition, as established by rule of the AMCC.
(3) Subject to the maximum daily dosages
			 established by rule of the AMCC, a maximum daily dosage shall not exceed 50 mg
			 of delta-9-tetrahydrocannabinol; provided, however, that the maximum daily
			 dosage may be increased but still subject to the maximum daily dosages
			 established by rule of the AMCC under either of the following circumstances:
(a) A registered certifying physician may
			 increase a patient's daily dosage if, after 90 days of continuous care under
			 the physician during which time the patient was using medical cannabis, the
			 physician determines that a higher daily dosage is medically appropriate;
			 provided that the maximum daily dosage under this paragraph may not exceed 75
			 mg of delta-9-tetrahydrocannabinol, and that the physician shall clearly
			 articulate in the patient's medical record the justification for the higher
			 daily dosage; or
(b) A registered
			 certifying physician may increase a patient's daily dosage if the patient has
			 been diagnosed with a terminal illness; provided that, if the recommended daily
			 dosage exceeds 75 mg of delta-9-tetrahydrocannabinol, the physician shall
			 notify the patient that the patient's driver's license will be
			 suspended.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.02 - Collaborative Drug Therapy Management Agreement Required

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Physicians and pharmacists may only
			 engage in Collaborative Drug Therapy Management when:
(a) An Agreement has been appropriately
			 executed and a written attestation has been filed with and approved by the
			 Board of Pharmacy and the Board of Medical Examiners; and
(b) The patient or the patient's authorized
			 representative has signed an Agreement-specific consent that the patient is to
			 receive services from a healthcare team, including a Collaborating
			 Pharmacist.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.03 - Eligibility Requirements

Current through Register Vol. 42, No. 9, June 28, 2024
(1) No
			 physician or pharmacist may engage in a Collaborative Drug Therapy Management
			 Agreement unless each Collaborating Physician and Collaborating Pharmacist who
			 is a party to the Agreement holds an active, unrestricted license in
			 Alabama.
(2) No physician may enter
			 into an Agreement with a Collaborating Pharmacist who is not licensed by the
			 Board of Pharmacy, does not have an active, unrestricted license, is not
			 employed by a pharmacy with an unrestricted permit (where applicable), and does
			 not comply with each term and requirement of the Board of Pharmacy's rule(s)
			 regarding Collaborative Drug Therapy Management.
(3) No pharmacist may enter into an Agreement
			 with a Collaborating Physician who is not licensed by the Board of Medical
			 Examiners, does not have an active, unrestricted license, and does not comply
			 with each term and requirement of the Board of Medical Examiners' rule(s)
			 regarding Collaborative Drug Therapy Management.
(4) A physician or pharmacist engaged in an
			 Agreement shall have:
(a) An active,
			 unrestricted license to practice medicine or pharmacy in the State of
			 Alabama;
(b) An active,
			 unrestricted Alabama Controlled Substances Certificate issued by the Board of
			 Medical Examiners or Board of Pharmacy;
(c) As to pharmacists providing services in a
			 facility permitted pursuant to Ala. Code §
									34-23-30 only, the pharmacy must
			 maintain an active unrestricted pharmacy permit and DEA registration;
(d) As to physicians only, shall have
			 practiced medicine for at least three years, or have practiced medicine for at
			 least one year, if the physician is certified by a specialty board approved by
			 the American Board of Medical Specialties (ABMS) or American Osteopathic
			 Association Bureau of Osteopathic Specialists (AOABOS); and
(e) Paid all collaborative practice fees due
			 to the Board of Medical Examiners and the Board of Pharmacy.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.05 - Limitations

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The scope of an
			 Agreement shall NOT include:
(a) Any person or
			 patient of a Collaborating Physician for whom such Collaborating Physician has
			 not prepared a patient-specific, drug- or drug class-specific,
			 disease-specific, or condition-specific plan of care based on a physical
			 examination of the patient by the Collaborating Physician within the past
			 twelve (12) months, with the exception of immunizations and acute,
			 uncomplicated illness or injury as well as the dispensing of opioid antagonists
			 as defined in Ala. Code §
									20-2-280; or
(b) The prescribing of controlled substances
			 listed or to be listed in the schedules under federal law and in Ala. Code
			 §§
									20-2-23,
			 20-2-25,
			 20-2-27,
			 20-2-29, and
			 20-2-31 and/or Ala. Admin. Code r.
			 420-7-2 and its Appendix.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.06 - Standards For Physicians

Current through Register Vol. 42, No. 9, June 28, 2024
(1)
			 Physicians engaged in an Agreement shall:
(a)
			 Provide professional medical oversight and instruction to the Collaborating
			 Pharmacist;
(b) Establish and
			 maintain a physician-patient relationship with each patient receiving services
			 under the Agreement, with the exception of immunization and opioid
			 antagonists;
(c) Be readily
			 available to the Collaborating Pharmacist through direct telecommunication for
			 consultation, assistance, and direction, or shall make arrangements for a
			 substitute physician to be readily available who is preapproved by the Board of
			 Medical Examiners, who practices in a specialty substantially similar to that
			 of the Collaborating Physician, and who is familiar with these rules;
(d) Collaborate with pharmacist(s) who agree
			 to be readily available to the physician through direct telecommunication for
			 consultation, assistance, and collaboration; and
(e) Contact each patient receiving treatment
			 by a pharmacist for an acute, uncomplicated illness or injury not later than
			 five (5) days following the first day of treatment to discuss follow-up care or
			 refer the patient for care from a physician with whom the patient has a
			 pre-existing relationship.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.07 - Standards For Pharmacists

Current through Register Vol. 42, No. 9, June 28, 2024
(1)
			 Pharmacists engaged in an Agreement shall:
(a)
			 Establish and maintain a pharmacist-patient relationship with each patient
			 receiving services under the Agreement;
(b) Be readily available to the Collaborating
			 Physician through direct telecommunication for consultation, assistance, and
			 direction; and
(c) Collaborate with
			 physician(s) who agree to be readily available to the pharmacist through direct
			 telecommunication for consultation, assistance, and collaboration.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.08 - Approval Of The Collaborative Drug Therapy Management Agreement

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A physician and
			 pharmacist shall not engage in Collaborative Drug Therapy Management until the
			 Agreement is approved by both the Board of Medical Examiners and the Board of
			 Pharmacy.
(2) Agreements must be
			 submitted to the Board of Medical Examiners and the Board of Pharmacy within
			 ten (10) days after the Agreement is signed by all parties.
(3) Any amendment or addendum to an Agreement
			 must be submitted to the Board of Medical Examiners and Board of Pharmacy
			 within ten (10) days after the amendment is signed by all parties.
(4) No Agreement, nor any amendment or
			 addendum thereto, shall be effective until it is approved by both the Board of
			 Pharmacy and the Board of Medical Examiners.
(5) Each Agreement submitted to the Board of
			 Medical Examiners shall be accompanied by a fee of three hundred dollars
			 ($300), except those Agreements submitted by a physician who is engaging in
			 Collaborative Drug Therapy Management at an indigent clinic, in which case the
			 fee may be $1. Each application requesting the nominal fee will be placed
			 before the Joint Committee for individual review. This fee is due and payable
			 concurrently with the submission of an application for a Collaborative Drug
			 Therapy Management Agreement. The fee is not refundable.
(6) Each Agreement submitted to the Board of
			 Pharmacy shall be accompanied by a fee of one hundred dollars ($100), except
			 those Agreements submitted by a pharmacist who is engaging in Collaborative
			 Drug Therapy Management at an indigent clinic, in which case the fee may be $1.
			 Each aplication requesting the nominal fee will be placed before the Joint
			 Committee for individual review. This fee is due and payable concurrently with
			 the submission of an application for a Collaborative Drug Therapy Management
			 Agreement. The fee is not refundable.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53; Act 2019-368 (
Code of Ala. 1975
, §
										34-23-77).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.11 - Reporting Requirement

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Any
			 physician engaging in a Collaborative Drug Therapy Management Agreement shall
			 be subject to disciplinary action by the Board of Medical Examiners if he or
			 she violates the terms of this Chapter or the terms of the Agreement. The Board
			 of Medical Examiners shall report to the Board of Pharmacy the initiation of
			 any proceeding against the physician or any conduct which it believes to be in
			 violation of any such Agreement.
(2) Any pharmacist engaging in a
			 Collaborative Drug Therapy Management Agreement shall be subject to
			 disciplinary action by the Board of Pharmacy if he or she violates the terms of
			 this Chapter or the terms of the Agreement. The Board of Pharmacy shall report
			 to the Board of Medical Examiners the initiation of any proceeding against the
			 pharmacist or any conduct which it believes to be in violation of any such
			 Agreement.
(3) Any party to an
			 Agreement which is voluntarily terminated shall, within ten (10) days of the
			 termination, notify their respective board.
(4) If the Alabama medical license of a
			 Collaborating Physician becomes inactive, revoked, suspended, restricted, or
			 placed on probation, then that physician's participation in any and all
			 Agreements shall be administratively terminated by operation of law. The Board
			 of Medical Examiners shall notify the Board of Pharmacy whenever disciplinary
			 action is taken against a Collaborating Physician's license or when a
			 Collaborating Physician's participation in an Agreement is terminated by
			 operation of law.
(5) If the
			 Alabama pharmacy license of a Collaborating Pharmacist becomes inactive,
			 revoked, suspended, restricted, or placed on probation, then that pharmacist's
			 participation in any and all Agreements shall be administratively terminated by
			 operation of law. The Board of Pharmacy shall notify the Board of Medical
			 Examiners whenever disciplinary action is taken against a Collaborating
			 Pharmacist's license or when a Collaborating Pharmacist's participation in an
			 Agreement is terminated by operation of law.
(6) A Collaborating Physician whose Alabama
			 medical license becomes inactive, revoked, suspended, restricted, or placed on
			 probation, or who is administratively terminated from an Agreement shall be
			 required to notify each party to the Agreement of said action. The
			 Collaborating Physician shall additionally be responsible for notifying each
			 patient served by the Agreement and shall bear the costs of such
			 notice.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53; Act 2019-368
				  (
Code of Ala. 1975
, §
										34-23-77).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.12 - Renewal

Current through Register Vol. 42, No. 9, June 28, 2024
(1) Agreements
			 shall be renewed by December 31 every two (2) years.
(2) Each Collaborating Physician and
			 Collaborating Pharmacist renewing an Agreement shall review the terms,
			 conditions, protocols, parties, and content of the Agreement and shall certify
			 that the information is accurate and complies with this Chapter.
(3) The fee for renewing an Agreement with
			 the Board of Medical Examiners shall be two hundred dollars ($200).
(4) The fee for renewing an Agreement with
			 the Board of Pharmacy shall be fifty dollars ($50).
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53; Act 2019-368 (
Code of Ala. 1975
, §
										34-23-77).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.13 - Joint Committee

Current through Register Vol. 42, No. 9, June 28, 2024
(1) There
			 shall be established a Joint Committee on Pharmacy Collaborative Practice for
			 the purpose of enabling a mechanism for the exchange of information between the
			 Board of Medical Examiners and the Board of Pharmacy on matters related to
			 physician-pharmacist collaboration.
(2) The Joint Committee shall be composed of
			 the following:
(a) Two (2) voting members of
			 the Board of Medical Examiners appointed by the Chairman of the Board of
			 Medical Examiners. For the initial term, one member shall be appointed to a
			 term concluding on December 31, 2022, and one member shall be appointed to a
			 term concluding on December 31, 2023. Thereafter, each appointee shall serve a
			 term of two (2) years.
(b) The
			 President and Vice-President of the Board of Pharmacy, or his or her appointee,
			 the terms of which shall coincide with their term as President or
			 Vice-President of the Board of Pharmacy.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.14 - Protocols

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The Board of
			 Medical Examiners and the Board of Pharmacy shall promulgate standard protocols
			 consistent with the recommendation of the Joint Committee establishing the
			 patient care services that may be rendered under an Agreement.
(2) Protocols deviating from the standard
			 protocols shall be submitted to the Joint Committee for recommendation for
			 approval. When evaluating whether to recommend the approval or denial of a
			 non-standard Protocol, the Joint Committee shall consider certain factors,
			 including, but not limited to:
(a) The
			 Collaborating Physician's and Collaborating Pharmacist's education, training,
			 experience, and specialty;
(b) The
			 Collaborating Physician's and Collaborating Pharmacist's disciplinary history
			 and any licensure restrictions;
(c)
			 FDA approved usages and recommendations;
(d) Whether a proposed Protocol is within the
			 current standard of care for treatment of the disease or condition specified in
			 the Protocol, including usages known as "off-label," and whether the use is
			 supported by evidence-based research;
(e) Whether the proposed Protocol creates an
			 undue risk of harm to patients; and
(f) The routine scope of practice and
			 services provided by the Collaborating Physician and Collaborating
			 Pharmacist.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.15 - Formulary

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The Board of
			 Medical Examiners and the Board of Pharmacy shall promulgate a standard
			 formulary of legend drugs and/or drug classes consistent with the
			 recommendations of the Joint Committee that may be utilized under an
			 Agreement.
(2) Any Formulary that
			 includes prescription drugs and/or drug classes additional to the standard
			 Formulary shall be submitted to the Joint Committee for recommendation for
			 approval. When evaluating whether to recommend the approval or denial of the
			 addition of a drug or drug class to a Formulary, the Joint Committee shall
			 consider certain factors, including, but not limited to:
(a) The Collaborating Physician's and
			 Collaborating Pharmacist's education, training, experience, and
			 specialty;
(b) The Collaborating
			 Physician's and Collaborating Pharmacist's disciplinary history and any
			 licensure restrictions;
(c) FDA
			 approved usages and recommendations;
(d) Whether the usage of the proposed drug(s)
			 or drug class(es) is within the current standard of care for treatment of the
			 disease or condition specified in the Protocol, including usages known as
			 "off-label," and whether the use is supported by evidence-based
			 research;
(e) Whether the use of
			 the proposed drug(s) or drug class(es) creates an undue risk of harm to
			 patients; and
(f) The routine scope
			 of practice and services provided by the Collaborating Physician and the
			 Collaborating Pharmacist.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.16 - Exclusion

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The foregoing
			 provisions of this Chapter shall not apply to a pharmacist licensed by the
			 Alabama State Board of Pharmacy who is employed by a Licensed Healthcare
			 Facility.
(2) The Board of Medical
			 Examiners and/or the Board of Pharmacy shall each have the authority to
			 identify those licensees who are exempt under this Rule.
(3) The Board of Medical Examiners or the
			 Board of Pharmacy may investigate or request additional documentation or
			 information from their respective licensee(s) to determine those who qualify
			 for the exemption under this Rule.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53; Act 2019-368
				  (
Code of Ala. 1975
, §
										34-23-77).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-26 - COLLABORATIVE PHARMACY PRACTICE › Section 540-X-26-.17 - Implementation

Current through Register Vol. 42, No. 9, June 28, 2024
Any physician and/or pharmacist currently participating in any
				activities described by this Chapter must be in full compliance with these
				rules no later than April 30, 2022. The provisions of this Chapter shall become
				enforceable by the Board of Medical Examiners and Board of Pharmacy on May 1,
				2022
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §
										34-24-53; Act 2019-368 (
Code of Ala. 1975
, §
										34-23-77).
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-27 - BRIDGE YEAR GRADUATE PHYSICIAN

Current through Register Vol. 42, No. 9, June 28, 2024
The
			 adopted version of this chapter by
			 Alabama
			 Administrative Monthly Volume XLII, Issue No. 08, May 31, 2024,
			 filed May 17, 2024 is not yet
			 available.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-28 - PHYSICIAN SUPERVISION OF ATHLETIC TRAINERS › Section 540-X-28-.01 - Definitions

Current through Register Vol. 42, No. 9, June 28, 2024
The following definitions will apply to these rules:
(1) ADVISORY COUNCIL. The Advisory Council of
			 the State Board of Medical Examiners and the Alabama Board of Athletic
			 Trainers, established pursuant to
Code of Ala. 1975
,
			 as amended, §
								34-40-3.2.
(2) ATHLETIC TRAINER. A person who is
			 licensed by the State Board of Athletic Trainers as an athletic trainer in
			 Alabama.
(3) BOARD OF ATHLETIC
			 TRAINERS. The Alabama Board of Athletic Trainers established pursuant to
Code of Ala. 1975
, as amended, §
								34-40-3.
(4) BOARD OF MEDICAL EXAMINERS. The State
			 Board of Medical Examiners established pursuant to
Code of Ala.
			 1975
, as amended, §
								34-24-53.
(5) EMERGENCY ACTION PLAN. A written document
			 which provides guidelines, defines personnel roles, and offers templates for
			 the treatment of a catastrophic injury in a given
(6) PHYSICIAN SUPERVISION. A formal
			 relationship between an athletic trainer and a licensed physician under which
			 the athletic trainer is authorized to practice as evidenced by a written
			 protocol approved by the State Board of Medical Examiners. Physician
			 supervision requires that there shall at all times be a continuing and close
			 supervisory relationship between the athletic trainer and the physician to whom
			 that athletic trainer is registered. The term does not require direct on-site
			 supervision of the athletic trainer; however, supervision does include the
			 professional oversight and direction required by these rules and by the written
			 guidelines established by the Board of Athletic Trainers and the Board of
			 Medical Examiners.
(7) PROTOCOL. A
			 document approved by the Board of Athletic Trainers and the Board of Medical
			 Examiners establishing the permissible functions and activities that an
			 athletic trainer may perform under the supervision of a physician.
(8) SUPERVISING PHYSICIAN. A physician
			 licensed by the Medical Licensure Commission of Alabama to whom an athletic
			 trainer is registered and who agrees in writing to supervise one or more
			 athletic trainers pursuant to the rules, regulations, and protocols established
			 by the Board of Medical Examiners and Board of Athletic Trainers.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53;
				  34-40-3.2.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-28 - PHYSICIAN SUPERVISION OF ATHLETIC TRAINERS › Section 540-X-28-.02 - Advisory Council

Current through Register Vol. 42, No. 9, June 28, 2024
(1) The
			 Advisory Council's primary purpose is to provide a forum for the exchange of
			 information between the Board of Medical Examiners and the Board of Athletic
			 Trainers and for the formulation of recommendations on matters relating to the
			 supervision of athletic trainers by physicians.
(2) The Advisory Council shall consist of the
			 following:
(a) Three (3) physicians appointed
			 by the Board of Medical Examiners. For the initial term, one member shall be
			 appointed to a term concluding on June 30, 2022, one member shall be appointed
			 to a term concluding on June 30, 2023, and one member shall be appointed to a
			 term concluding on June 30, 2024. Thereafter, each appointee shall serve a term
			 of three (3) years.
(b) Three (3)
			 athletic trainers appointed by the Board of Athletic Trainers. For the initial
			 term, one member shall be appointed to a term concluding on June 30, 2022, one
			 member shall be appointed to a term concluding on June 30, 2023, and one member
			 shall be appointed to a term concluding on June 30, 2024. Thereafter, each
			 appointee shall serve a term of three (3) years.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-28 - PHYSICIAN SUPERVISION OF ATHLETIC TRAINERS › Section 540-X-28-.03 - Protocols

Current through Register Vol. 42, No. 9, June 28, 2024
(1) There shall be
			 a standard general practice protocol, approved by both the Board of Athletic
			 Trainers and the Board of Medical Examiners, which shall set forth the baseline
			 scope of practice, privileges, and permissible skills of all athletic trainers
			 licensed to practice in this state.
(2) There may be a standard specialty
			 practice protocol for each of the following areas of practice for athletic
			 trainers:
(a) Clinic and Hospital
			 Protocol;
(b) Secondary Schools
			 Protocol;
(c)
			 Collegiate/Professional League Protocol; and
(d) Occupational Setting Protocol.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-28 - PHYSICIAN SUPERVISION OF ATHLETIC TRAINERS › Section 540-X-28-.04 - Registration

Current through Register Vol. 42, No. 9, June 28, 2024
Each athletic trainer shall be licensed by the Board of
				Athletic Trainers and be registered with a supervising physician prior to
				engaging in athletic training practice as defined by Ala. Code §
								34-40-2(4).
Registration of an athletic trainer with a supervising
				physician for the practice of athletic training shall be accomplished in the
				following manner:
(1) A completed
			 application for registration shall be submitted to the Board of Athletic
			 Trainers; and
(2) A detailed
			 protocol(s) which sets forth the anticipated functions and activities of the
			 athletic trainer and is signed by the supervising physician and the athletic
			 trainer shall accompany the application.
(3) The athletic trainer and the supervising
			 physician may be personally interviewed at the discretion of the Board of
			 Athletic Trainers, Board of Medical Examiners, or the Advisory
			 Council.
Author:
Alabama Board of Medical
				  Examiners
Statutory Authority:
Code of Ala.
				  1975
, §§
										34-24-53;
				  34-40-3.2.
Alabama Administrative Code › Title 540 - ALABAMA BOARD OF MEDICAL EXAMINERS › Chapter 540-X-28 - PHYSICIAN SUPERVISION OF ATHLETIC TRAINERS › Section 540-X-28-.05 - Limitations On The Physician Supervision Of Athletic Trainers

Current through Register Vol. 42, No. 9, June 28, 2024
(1) A licensed
			 physician may supervise up to fifteen (15) athletic trainers.
(2) Requests to supervise more than fifteen
			 (15) athletic trainers must be submitted to the Advisory Council and approved
			 in writing by the Board of Athletic Trainers and Board of Medical Examiners.
			 When evaluating whether to recommend the approval or denial of a physician's
			 request to supervise more than fifteen (15) athletic trainers, the Advisory
			 Council shall consider certain factors, including, but not limited to:
(a) The supervising physician's
			 availability;
(b) The parties'
			 disciplinary history and any licensure restrictions;
(c) The parties' practice settings;
(d) The parties' educational preparation,
			 experience, and specialty;
(e)
			 Whether the proposed protocol creates an undue risk of harm to patients;
			 and
(f) The complexity and risk of
			 procedures to be performed.
After consideration of the factors listed herein, the Advisory
				Council may make a non-binding recommendation of approval or denial of a
				physician's request to supervise more than fifteen (15) athletic
				trainers.